X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - NLM.NIH.GOV - DailyMed Drug Label Updates - 25/Jun 04:00

CELEBREX (celecoxib) capsule [PFIZER LABORATORIES DIV PFIZER INC]

Updated Date: Tue, 25 Jun 2024 00:00:00 EDT

Articles similaires

Sorry! Image not available at this time

CELEBREX (celecoxib) capsule [PFIZER LABORATORIES DIV PFIZER INC]

nlm.nih.gov - 23/Sep 04:00

Updated Date: Mon, 23 Sep 2024 00:00:00 EDT

Sorry! Image not available at this time

CELEBREX (celecoxib) capsule [Viatris Specialty LLC]

nlm.nih.gov - 23/Sep 04:00

Updated Date: Mon, 23 Sep 2024 00:00:00 EDT

Sorry! Image not available at this time

RUXIENCE (rituximab-pvvr) injection, solution [Pfizer Laboratories Div Pfizer Inc]

nlm.nih.gov - 27/Sep 04:00

Updated Date: Fri, 27 Sep 2024 00:00:00 EDT

Sorry! Image not available at this time

PAXLOVID (nirmatrelvir and ritonavir) kit [Pfizer Laboratories Div Pfizer Inc]

nlm.nih.gov - 27/Sep 04:00

Updated Date: Fri, 27 Sep 2024 00:00:00 EDT

Sorry! Image not available at this time

NORVASC (amlodipine besylate) tablet [PFIZER LABORATORIES DIV PFIZER INC]

nlm.nih.gov - 26/Sep 04:00

Updated Date: Thu, 26 Sep 2024 00:00:00 EDT

Sorry! Image not available at this time

CELECOXIB capsule [REMEDYREPACK INC.]

nlm.nih.gov - 20/Sep 04:00

Updated Date: Fri, 20 Sep 2024 00:00:00 EDT

Sorry! Image not available at this time

PENBRAYA (meningococcal groups a, b, c, w, and y vaccine) kit [Pfizer Laboratories Div Pfizer Inc]

nlm.nih.gov - 23/Sep 04:00

Updated Date: Mon, 23 Sep 2024 00:00:00 EDT

Sorry! Image not available at this time

FLUOXETINE (fluoxetine hydrochloride) capsule [TIME CAP LABORATORIES, INC.]

nlm.nih.gov - 27/Sep 04:00

Updated Date: Fri, 27 Sep 2024 00:00:00 EDT

Sorry! Image not available at this time

LOXAPINE capsule [Elite Laboratories, Inc.]

nlm.nih.gov - 02/Oct 04:00

Updated Date: Wed, 02 Oct 2024 00:00:00 EDT

Sorry! Image not available at this time

CEPHALEXIN capsule [REMEDYREPACK INC.]

nlm.nih.gov - 25/Sep 04:00

Updated Date: Wed, 25 Sep 2024 00:00:00 EDT

Les derniers communiqués